Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹80,634Qualified Item Categories: Line Probe Assay Kit for First Line Drugs under NTEP 43 A OKHLA INDUSTRIAL ESTATE PHASE III NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | Item Categories: Line Probe Assay Kit for First Line Drugs under NTEP | L1 | Qualified |
Tender Value
₹80,000
EMD Value
Exempted
Closing Date
24 Aug 2024, 5:00 pmClosed
Line Probe Assay Kit for First Line Drugs under NTEP (Q1)
6784593
GEM/2024/B/5291661
Single Packet Bid
Line Probe Assay Kit for First Line Drugs under NTEP
GeM Contract
15 days
Madhya Pradesh; Bhopal
Total value wise evaluation
PRODUCT
Awarded to BIOMERIEUX INDIA PRIVATE LIMITED
₹80,634
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| HAIN LIFESCIENCE Line Probe Assay Kit for First Line Drugs | HAIN LIFESCIENCE / Genotype MTBDRplus V2 (96Tests) | HSN not specified by seller | 1 pieces | 80,634 | 80,634 |
2 documents required · 2 mandatory
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Line Probe Assay Kit for First Line Drugs under NTEP (Q1) | Anand Kumar Tamboli 462038,Raisen By Pass Road Karond Bhopal | 1 | 15 days |
Exempted
7 Oct 2024
14 Aug 2024
24 Aug 2024
contract_GEMC-511687722322595.pdf
GEM_CONTRACT • 0.06 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6784593.pdf
GEM_BID
line_probe_assay_for_first_line_drugs_2024-07-05-17-12-42_a1cae39c6006b56298b42101610a7930.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .